Cellectis BioResearch Launches Compact TALENTM the Next Generation of TAL Effector Nucleases
PARIS--(BUSINESS WIRE)--Regulatory News: Cellectis bioresearch, a subsidiary of Cellectis Group (Paris:ALCLS), the genome engineering specialist, announces the launch of a monomeric Compact TALENTM, that allows efficient transfection and genome editing in sensitive cells.
Help employers find you! Check out all the jobs and post your resume.